FridayMar 17, 2023 11:30 am

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Marks Entry into Mexico LTL Market with Launch of Fr8Now

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company with a custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning that offers a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region. The company today announced the launch of its new brand Fr8Now, a digital freight-matching platform that offers less-than-truckload (“LTL”) services in Mexico. With Fr8Now, Freight Technologies is marking its entry into the highly fragmented and rapidly growing LTL market in Mexico, which has few established players. “Our team has worked tirelessly to bring Fr8Now operational,” said Javier Selgas, CEO of Fr8Tech. “With…

Continue Reading

ThursdayMar 16, 2023 1:36 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Positioning to Deliver Class 1 and 3 Vehicles, Enter Next Phase of Crossover Program

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today released a statement from its CEO to address recent investor inquires. Among the highlights, Mullen anticipates making Class 1 EV deliveries to various commercial customers before the end of March 2023 and believes the company’s cash on hand and expected firm cash commitments will provide enough capital to execute on its business plan over the next 12 months. “I believe we have all the pieces in place between our product, factories and strategic expertise to execute on our plans to deliver our Class 1 and Class 3 vehicles this…

Continue Reading

ThursdayMar 16, 2023 1:11 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Secures Bulk Order from Florida-Based Reseller

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced that Transportation Solutions & Lighting (“TS&L”), a Florida-based reseller of Knightscope technologies, submitted a purchase order for another 10 new K1 Blue Light Towers. This brings TS&L’s total order for the month of March to 40 emergency communication devices. “Campuses are transitioning away from traditional emergency call boxes to more cost-effective systems using cellular and satellite communications powered by solar energy,” said John Discepolo, director of sales - safety and security at TS&L. “We are able to affordably install Knightscope’s portfolio of…

Continue Reading

WednesdayMar 15, 2023 2:01 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Announces Q4 and FY 2022 Results

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, on Tuesday announced business updates and financials for the fourth quarter and full year ended Dec. 31, 2022. “We closed out our first year as a public company with notable achievements,” said Jun Pei, Cepton’s co-founder and CEO. “We are in the final stages of preparation for the start of the production launch of our lidar for OEM customers, we announced our next-generation Vista(R)-X120 Plus lidar to meet future OEM requirements and closed the $100 million investment from Koito. We look forward to capitalizing on our extensive…

Continue Reading

WednesdayMar 15, 2023 1:50 pm

TinyGemsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Positive Results from IND-Enabling Toxicology Study of SP-26

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it has achieved positive results for its toxicology study of SP-26, its novel time-released, dosage-controlled formulation of ketamine. In collaboration with Experimur, a Frontage Laboratories company, Silo Pharma tested SP-26 in a toxicology and tolerability study in mini pigs using an ascending (descending) dosing regimen in advance of initiating clinical studies. “Today’s positive results are an important step as we move closer to achieving all needed components to plan human trials of SP-26.” said Eric Weisblum, chief executive officer of…

Continue Reading

WednesdayMar 15, 2023 10:41 am

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) CEO Pens Latest Company Blog, Robot Roadshow to Make a Stop in Arizona

Knightscope (NASDAQ: KSCP) CEO William Santana authored the company’s latest blog release, titled “7 Questions About AI Robots.” In the blog, Li notes the accelerating trend of artificial intelligence (“AI”) being a part of everyday life, from cleaning and disinfecting to lawn care and security. Li says he is flooded with questions about AI, and the newest blog post becomes an ideal avenue for him to answer seven of the most common questions that people ask him about AI and Knightscope, including how the company currently uses the tech and the potential role AI has in future security applications. “As…

Continue Reading

TuesdayMar 14, 2023 2:38 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) CEO Shares Insight into the Future of A.I.

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced a new blog on artificial intelligence (“A.I.”). The announcement reads, “As we enter the fourth industrial revolution, an era that will be defined and driven by extreme automation and ubiquitous connectivity, A.I. is altering the course of our future and the way we interact with technology and each other. Knightscope chairman and CEO, William Santana Li, answers seven questions about A.I., providing insight into how it is currently being used by the company, as well as its potential role in future security…

Continue Reading

MondayMar 13, 2023 11:35 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces It Has No Exposure to Silicon Valley Bank Issues

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced that it is aware that the Federal Deposit Insurance Corp. has taken control of Silicon Valley Bank (“SVB”) due to liquidity concerns. CNS Pharmaceuticals does not hold any deposits or investments at SVB. To view the full press release, visit https://ibn.fm/4FTuQ About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the…

Continue Reading

FridayMar 10, 2023 10:36 am

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys ‘Optimus’ ASR for Fifth Year Running

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, announced that a long-time real estate client has renewed its K5 Autonomous Security Robot (“ASR”) contract for the fifth consecutive year. The announcement reads, “The client’s affectionately named ‘Optimus Crime’ ASR patrols a San Francisco Bay Area mixed-use parking structure to help protect the property, visitors and their vehicles. To learn more about how robots serve commercial real estate and to make properties more desirable for tenants and guests, read Knightscope’s recommendations for real estate investors/developers here.” To view the full press release, visit…

Continue Reading

ThursdayMar 09, 2023 12:29 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls First Patient in Switzerland in Potentially Pivotal Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that the first patient in Switzerland has been enrolled in the company’s ongoing global trial. The potentially pivotal trial is focused on evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. “The active patient enrollment we continue to build across our clinical trial sites in Europe is incredibly encouraging. Our team is laser focused on getting additional clinical trial sites online so that…

Continue Reading

Contact us: (512) 354-7000